Try our Advanced Search for more refined results

2nd Cancer Biotech Of The Week Soars In Market Debut

By Chelsea Naso ( December 19, 2014, 12:29 PM EST) -- Juno Therapeutics Inc. soared nearly 63 percent in its Nasdaq debut Friday after raising $265 million in an upsized initial public offering, making it the second cancer immunotherapy developer this week to draw strong interest and the largest biotech by diluted market capitalization to list in 2014....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!